4-1BB-mediated signals confer protection against folic acid-induced nephrotoxicity

Kidney and Blood Pressure Research

Volumn 36, Issue 1, 2012, Pages 10-17

  Li, Xiaozhong ^a,b   Dai, Jihong ^a   Qiu, Yuhua ^a   Zhang, Xueguang ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Agonistic anti 4 1BB monoclonal antibodies (4 1BB mAb); FAN (Folic acid induced nephrotoxicity); Tubulointerstitial lesions

Indexed keywords

4 1BB MONOCLONAL ANTIBODY; CD137 ANTIGEN; FOLIC ACID; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HISTOCHEMISTRY; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RENAL PROTECTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD137; DISEASE MODELS, ANIMAL; FIBROSIS; FOLIC ACID; IMMUNE SYSTEM; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MICE; MICE, INBRED STRAINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84863532349     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000339022     Document Type: Article

References (20)

1. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ: Role of immunocompetent cells in nonimmune renal diseases. Kidneylnt 2001;59:1626-1640.
2. Bloudícková S, Rajnoch J, Lodererová A, Honsová E, Viklický O: Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat. Kidney Blood Press Res 2006;29:60-66.
3. Rodríguez-Iturbe B, Quiroz Y, Shahkarami A, Li Z, Vaziri ND: Mycophenolate mofetil ameliorates nephropathyin the obese Zucker rat. Kidney Int 2005;68:1041-1047.
4. Tapia E, Franco M, Sánchez-Lozada LG, Soto V, Avila-Casado C, Santamaría J, Quiroz Y, Rodríguez-Iturbe B, Herrera-Acosta J: Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistenthypertension. Kidney Int 2003;63:994-1002.
5. Koppelstaetter C, Aydin S, Abberger T, Wolf AM, Mayer G, Pfaller W: Cyclosporine Ainduces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol 2007;293:F831-838.
6. Vinay DS, Kwon BS: Immunotherapy targeting 4-1BB and its ligand. Int J Hematol 2006;83:23-28.
7. Lee EA, Kim JE, Seo JH, Kwon BS, Nam SH, Kwon B, Cho HR: 4-1BB (CD137) signals depend upon CD28 signals in all immune responses. Exp Mol Med 2006;38:606-615.
8. Seo SK, Choi JH, Kim YH, Kang WJ, Park HY, Suh JH, Choi BK, Vinay DS, Kwon BS: 4-lBB-mediated immunotherapy of rheumatoid arthritis. Nat Med 2004;10:1088-1094.
9. Vinay DS, Choi JH, Kim JD, Choi BK, Kwon BS: Role of endogenous 4-1BB in the development of systemic lupus erythematosus. Immunology 2007;122:394-400.
10. Sun Y, Lin X, Chen HM, Wu Q, Subudhi SK, Chen L, Fu YX: Administration ofagonistic anti-4-lBB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol 2002;168:1457-1465.
11. Choi BK, Asai T, Vinay DS, Kim YH, Kwon BS: 4-lBB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms. Cytokine 2006;34:233-242.
12. Yuan HT, Li XZ, Pitera JE, Long DA, Woolf AS: Peritubular capillary loss after mouse acute nephrotoxicity correlates with down regulation ofvascular endothelial growth factor-A and hypoxia-inducible factor-lalpha. Am J Pathol 2003;163:2289-2301.
13. Vinay DS, Cha K, Kwon BS: Dual immunoregulatory pathways of 4-1BB signaling. J Mol Med 2006;84:726-736.
14. Vinay DS, Kim JD, Asai T, Choi BK, Kwon BS: Absence of 4 IBB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice. Invest Ophthalmol Vis Sci 2007;48:4608-4615.
15. Vinay DS, Kwon BS: Immunotherapy targeting 4-1BB and its ligand. Int J Hematol 2006;83:23-28.
16. Ju SA, Park SM, Lee SC, Kwon BS, Kim BS: Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced byanti-4-1BB monoclonal antibody. Mol Cells 2007;24:132-138.
17. Penberthy WT: Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease. Curr Drug Metab 2007;8:245-266.
18. Elpek KG, Yolcu ES, Franke DD, Lacelle C, Schabowsky RH, Shirwan H: Exvivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol 2007;179:7295-7304.
19. Park MJ, Min SY, Park KS, Cho YG, Cho ML, Jung YO, Park HS, Chang SH, Cho SG, Min JK, Park SH, Kim HY: Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerated, collagen-induced arthritis mouse model. Arthritis Res Ther 2008;10:R11.
20. Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001;78:S206-11.